|
Volumn 20, Issue 12, 2010, Pages 3772-3776
|
Novel trivalent anti-influenza reagent
|
Author keywords
Anti influenza virus infection; Computer based drug design; Scaffold; Trivalent glycoside
|
Indexed keywords
ANTIVIRUS AGENT;
CYCLOPEPTIDE;
GLUTAMINE;
HEMAGGLUTININ;
LACTOSE;
TRISANILINE LACTOSE;
TRISANILINE SIALYLLACTOSE;
TRISPHENOL LACTOSE;
TRISPHENOL SIALYLLACTOSE;
UNCLASSIFIED DRUG;
ARTICLE;
BINDING SITE;
CELL STRAIN;
COMPUTER SIMULATION;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HEMAGGLUTINATION INHIBITION;
HYDROGEN BOND;
INFLUENZA VIRUS;
NONHUMAN;
RECEPTOR BINDING;
VIRUS INHIBITION;
VIRUS REPLICATION;
ANIMALS;
ANTIVIRAL AGENTS;
CELL LINE;
DOGS;
DRUG DESIGN;
HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS;
HUMANS;
INFLUENZA A VIRUS, H1N1 SUBTYPE;
INFLUENZA, HUMAN;
MODELS, MOLECULAR;
PEPTIDES, CYCLIC;
PLAQUE ASSAY;
RECEPTORS, VIRUS;
VIRUS REPLICATION;
ORTHOMYXOVIRIDAE;
|
EID: 77954212928
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2010.04.060 Document Type: Article |
Times cited : (15)
|
References (21)
|